- Trials with a EudraCT protocol (309)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
309 result(s) found for: Visceral.
Displaying page 1 of 16.
EudraCT Number: 2005-001048-22 | Sponsor Protocol Number: 990312 | Start Date*: 2005-12-29 |
Sponsor Name:Göteborg University, Institute for Internal Medicine | ||
Full Title: Rosuvastatin in Visceral Adiposity. A 26-week, single center, randomised, placebo-controlled, double-blind, parallel-group study to evaluate the effect of rosuvastatin on visceral adipose tissue in... | ||
Medical condition: Visceral adiposity | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-003072-31 | Sponsor Protocol Number: 2378 | Start Date*: 2018-05-15 |
Sponsor Name:VU University Medical Center | ||
Full Title: The effects of sex hormone administration on marrow and visceral adiposity | ||
Medical condition: Healthy transgender persons (the effect of differences in sex hormones on the amount of bone marrow fat) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004596-72 | Sponsor Protocol Number: EXCALIBUR | Start Date*: 2016-04-06 | |||||||||||
Sponsor Name:FONDAZIONE IRCCS "ISTITUTO NAZIONALE DEI TUMORI" | |||||||||||||
Full Title: A phase II study evaluating the efficacy of enzalutamide and the role of ARv7 in metastatic castration resistant prostate cancer (mCRPC) patients with visceral disease | |||||||||||||
Medical condition: metastatic prostate cancer resistant to castration with visceral disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001551-22 | Sponsor Protocol Number: RECIPE2014 | Start Date*: 2014-12-18 |
Sponsor Name:Charité Universitätsmedizin | ||
Full Title: Reduction of postoperative wound infections by antiseptica | ||
Medical condition: Laparotomy wound after closure of the fascia after visceral surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-003797-25 | Sponsor Protocol Number: GH100-013 | Start Date*: 2005-12-09 |
Sponsor Name:ConjuChem, Inc. | ||
Full Title: A Multicenter, Randomized, Placebo-controlled, Double-blind Phase 2 Study to Evaluate the Efficacy and Safety of CJC-1295 administered for 12 weeks in HIV-Infected Patients with HIV-associated Visc... | ||
Medical condition: Patients 18 to 65 years old with HIV-associated visceral obesity, on a stable antiviral regimen for at least 6 weeks, with a viral load ≤1,000 copies/mL and CD4 count ≥200 cells/mm3, a body mass in... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2010-024414-61 | Sponsor Protocol Number: HJT-PEDOB-MET1 | Start Date*: 2011-12-21 | ||||||||||||||||
Sponsor Name:Hospital de Girona Dr Josep Trueta | ||||||||||||||||||
Full Title: Efectos endocrino-metabólicos, sobre la adiposidad visceral y parámetros de riesgo cardiovascular de la administración de metformina en niños prepuberales con obesidad y marcadores de riesgo para e... | ||||||||||||||||||
Medical condition: Obesidad Infantil | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001900-12 | Sponsor Protocol Number: PFD-ESC | Start Date*: 2004-09-26 |
Sponsor Name:SERVICIO DE PSIQUIATRIA. HOSPITAL UNIVERSITARI VALL D'HEBRON | ||
Full Title: ENSAYO CLINICA DOBLE CIEGO, ALEATORIZADO Y PARALELO SOBRE EL EFECTO DE ESCITALOPRAM vs REBOXETINA EN LA SENSIBILIDAD SOMATICA Y VISCERAL EN PACIENTES CON TRASTORNO DEPRESIVO MAYOR | ||
Medical condition: Trastorno depresivo mayor | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002568-27 | Sponsor Protocol Number: PM-C-0172 | Start Date*: 2006-05-08 | |||||||||||
Sponsor Name:Sanofi-Synthelabo Groupe | |||||||||||||
Full Title: A randomized, double blind, two-arm placebo controlled, 12-Month study of the effects of rimonabant 20mg once daily on the amount and the activity of visceral fat in abdominally obese patients with... | |||||||||||||
Medical condition: Abdominally obese patients with metabolic syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) DK (Completed) SE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-000260-14 | Sponsor Protocol Number: UC-0140/1901 | Start Date*: 2020-01-30 | ||||||||||||||||
Sponsor Name:UNICANCER | ||||||||||||||||||
Full Title: Open-label, randomized, multicenter, phase III study, comparing standard chemotherapy to standard combination of endocrine therapy with Abemaciclib as initial Metastatic treatment among patients wi... | ||||||||||||||||||
Medical condition: Untreated metastatic Estrogen Receptor positive (ER+), Human Epidermal Growth Factor Receptor-2 negative (HER2-) breast cancer with visceral involvement. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: FR (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000008-34 | Sponsor Protocol Number: 07.IBS.1 | Start Date*: 2007-09-13 | |||||||||||
Sponsor Name:North West London Hospitals NHS Trust | |||||||||||||
Full Title: Bacteria and host immune response as factors modulating visceral afferent processing in Irritable Bowel Syndrome: manipulation of visceral hypersensitivity with probiotic bacteria | |||||||||||||
Medical condition: Irritable Bowel Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003648-22 | Sponsor Protocol Number: SAKK_2118 | Start Date*: 2020-02-26 | ||||||||||||||||
Sponsor Name:SAKK | ||||||||||||||||||
Full Title: Ribociclib-endocrine combination therapy versus chemotherapy as 1st line treatment in patients with visceral metastatic breast cancer. A multicenter, randomized phase III trial. | ||||||||||||||||||
Medical condition: Histologically or cytologically confirmed diagnosis of HR-positive, HER2-negative advanced stage breast cancer with measurable visceral metastases . | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: BE (Completed) AT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-002814-38 | Sponsor Protocol Number: SP005 | Start Date*: 2013-09-27 | |||||||||||
Sponsor Name:SOTIO a.s. | |||||||||||||
Full Title: A Randomized, Double Blind, Multicenter, Parallel-group, Phase III study to evaluate efficacy and safety of DCVAC/PCa versus Placebo in Men with metastatic Castration Resistant Prostate Cancer elig... | |||||||||||||
Medical condition: metastatic castrate-resistant prostate cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: SE (Completed) GB (Completed) DE (Completed) BE (Completed) CZ (Completed) IT (Completed) NL (Completed) ES (Completed) HU (Completed) PT (Completed) BG (Completed) SK (Completed) PL (Completed) HR (Completed) AT (Completed) LV (Completed) LT (Completed) DK (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003968-56 | Sponsor Protocol Number: CAAA617C12301 | Start Date*: 2021-04-06 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: PSMAddition : An International Prospective Open-label, Randomized, Phase III Study comparing 177Lu-PSMA-617 in combination with Standard of Care, versus Standard of Care alone, in adult male patien... | |||||||||||||
Medical condition: PSMA-positive metastatic hormone-sensitive prostate cancer (mHSPC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: FR (Trial now transitioned) SE (Trial now transitioned) DE (Trial now transitioned) DK (Trial now transitioned) NL (Trial now transitioned) PL (Trial now transitioned) BE (Trial now transitioned) AT (Trial now transitioned) CZ (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000447-27 | Sponsor Protocol Number: USKH_VL1 | Start Date*: 2012-07-25 |
Sponsor Name:Universitätsklinikum Schleswig-Holstein, Campus Kiel | ||
Full Title: Open Label Study for the Functional Characterization of Drug Metabolism and Transport in patients before routine visceral surgery | ||
Medical condition: Pharmacokinetic trial in patients, with a good general condition before standard abdominal surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Temporarily Halted) | ||
Trial results: (No results available) |
EudraCT Number: 2009-016246-12 | Sponsor Protocol Number: HSJD-GHMET | Start Date*: 2010-03-29 |
Sponsor Name:HOSPITAL SANT JOAN DE DÉU | ||
Full Title: Efectos Sobre Marcadores de Riesgo Cardiovascular de la Adición de Metformina al Tratamiento con Hormona de Crecimiento en Pacientes Prepuberales con Antecedentes de Peso Bajo al Nacer para la Edad... | ||
Medical condition: cambios endocrinometabólicos y de composición corporal en pacientes con bajo peso al nacimiento sin recuperación de peso/ talla en tratamiento con hormona de crecimiento | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-009944-21 | Sponsor Protocol Number: HSJD-SGA-MET10 | Start Date*: 2009-07-20 |
Sponsor Name:HOSPITAL SANT JOAN DE DÉU | ||
Full Title: EFECTOS ENDOCRINO-METABÓLICOS Y SOBRE LA ADIPOSIDAD VISCERAL DE LA ADMINISTRACIÓN DE METFORMINA EN NIÑOS PREPUBERALES CON BAJO PESO AL NACER PARA LA EDAD GESTACIONAL, RECUPERACIÓN POSTNATAL ESPONTÁ... | ||
Medical condition: PRENATAL GROWTH RESTRAINT FOLLOWED BY EXCESSIVE CATCH-UP IN WEIGHT AND ASSOCIATED METABOLIC SYNDROME RETRASO DEL CRECIMIENTO INTRAUTERINO ASOICADO A CRECIMIENTO RECUPERADOR EXCESIVO Y SINDROME MET... | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-004100-35 | Sponsor Protocol Number: FSJD-PIOSPIMET-2012 | Start Date*: 2012-12-20 |
Sponsor Name:Fundació per la Recerca i la Docència Sant Joan de Déu | ||
Full Title: A prospective, open-label, randomized, two-armed clinical trial to evaluate the efficacy and safety of a combination of ethinyl-estradiol and levonorgestrel versus a low-dose combination of pioglit... | ||
Medical condition: Ovarian hyperandrogenism | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-005092-24 | Sponsor Protocol Number: FSJD-PIOSPIMET-2015 | Start Date*: 2016-01-22 |
Sponsor Name:FUNDACIÓ SANT JOAN DE DÉU | ||
Full Title: A prospective, open-label, randomized, two-armed clinical trial to evaluate the efficacy and safety of a combination of ethinyl-estradiol and levonorgestrel versus a low-dose combination of pioglit... | ||
Medical condition: ovarian hyperandrogenism with hyperinsulinaemia | ||
Disease: | ||
Population Age: Adolescents, Under 18 | Gender: Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002529-27 | Sponsor Protocol Number: D5339C00001 | Start Date*: 2021-02-24 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Modular Phase 2a Multicentre Open-Label Study to Investigate DNA-damage Response Agents (or Combinations) in Patients With Advanced Cancer Whose Tumours Contain Molecular Alterations (PLANETTE) | |||||||||||||
Medical condition: Advanced Cancer Whose Tumours Contain Molecular Alterations | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003865-32 | Sponsor Protocol Number: TOK-200-11 | Start Date*: 2014-02-12 | |||||||||||
Sponsor Name:Tokai Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Pharmacokinetic and Pharmacodynamic Translational Investigation of Galeterone in Patients with Metastatic Castration Resistant Prostate Cancer | |||||||||||||
Medical condition: Metastatic Castration Resistant Prostate Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (Prematurely Ended) ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
